TVGN — Tevogen Bio Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $228.03m
- $239.50m
- 12
- 25
- 68
- 26
Annual cashflow statement for Tevogen Bio Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -15.6 | -22 | -60.5 | -13.7 |
| Depreciation | ||||
| Non-Cash Items | 11.6 | 13 | 51.9 | 1.57 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -1.25 | 0.258 | 0.293 | -0.005 |
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Cash from Operating Activities | -5.27 | -8.66 | -8.17 | -12 |
| Capital Expenditures | -0.11 | -0.479 | -0.133 | — |
| Purchase of Fixed Assets | ||||
| Cash from Investing Activities | -0.11 | -0.479 | -0.133 | — |
| Financing Cash Flow Items | — | — | -0.128 | 0.229 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 12.5 | 7.5 | 3.87 | 12.2 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 7.12 | -1.63 | -4.43 | 0.231 |